OLMA financials
Olema Pharmaceuticals (OLMA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
OLMA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$178.70M | -$162.45M | -1.87 |
| 2024 | – | – | -$142.26M | -$129.47M | -2.20 |
| 2023 | – | – | -$104.96M | -$96.66M | -2.14 |
| 2022 | – | – | -$106.99M | -$104.79M | -2.62 |
| 2021 | – | – | -$71.49M | -$71.10M | -1.80 |
| 2020 | – | – | -$21.53M | -$23.99M | -3.42 |